License and Collaboration Agreements (Tables)

3 Months Ended

Mar. 31, 2021

License And Collaboration Agreements [Abstract]

License, Collaboration and Other Revenue

In accordance with our collaboration agreements, we recognized license, collaboration and other revenue as follows (in thousands):

		Three months ended March 31,
Partner	Drug Candidate	2021		2020
Bristol-Myers Squibb Company	Bempegaldesleukin	$	—	$	25,000
Eli Lilly and Company	NKTR-358	—		1,259
Other		54		1,256
License, collaboration and other revenue		$	54	$	27,515